Mineralys Therapeutics Inc.
Clinical trials sponsored by Mineralys Therapeutics Inc., explained in plain language.
-
New pill aims to tame sleep apnea and high blood pressure together
Disease control CompletedThis study tested whether a daily oral medication called lorundrostat could help adults who have both moderate-to-severe obstructive sleep apnea and high blood pressure. In this 48-person trial, participants took either the study drug or a placebo for four weeks, then switched af…
Phase: PHASE2 • Sponsor: Mineralys Therapeutics Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New pill targets stubborn high blood pressure when standard meds fail
Disease control CompletedThis study tested whether a new drug called lorundrostat could help lower blood pressure in people whose high blood pressure wasn't controlled by their current medications. 285 adults with uncontrolled hypertension took either the new drug or a placebo pill in addition to a stand…
Phase: PHASE2 • Sponsor: Mineralys Therapeutics Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug shows promise for stubborn high blood pressure
Disease control CompletedThis large, completed Phase 3 trial tested whether a new drug called lorundrostat could lower blood pressure in people whose high blood pressure wasn't controlled despite taking 2 to 5 other medications. Over 1,000 participants were randomly assigned to receive either the new dru…
Phase: PHASE3 • Sponsor: Mineralys Therapeutics Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC